Pentavalent DTaP-Hep B-IPV

NCT00133445 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

5

Enrollment

NIH

Sponsor class

Conditions

Diphtheria
Hepatitis B
Poliomyelitis
Pertussis
Tetanus

Interventions

BIOLOGICAL: DTaP-Hep B-IPV Vaccine
BIOLOGICAL: Monovalent Hep B Vaccine
DRUG: Placebo

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)